申请人:Vertex Pharmaceuticals Incorporated
公开号:EP2789606A1
公开(公告)日:2014-10-15
Compounds of the present invention, and pharmaceutically acceptable composition thereof, are useful as modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). The present invention also relates to methods of treating CFTR mediated diseases using compounds of the present invention.
本发明的化合物及其药学上可接受的组合物可用作 ATP 结合盒("ABC")转运体或其片段(包括囊性纤维化跨膜传导调节器("CFTR"))的调节剂。 本发明还涉及使用本发明化合物治疗 CFTR 介导的疾病的方法。